| Names | |
|---|---|
|
IUPAC name
[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl(hydroxy-phosphonooxyphosphoryl)hydrogen phosphate
|
|
| Other names
CTP; Cytidine-5'-triphosphate; Cytidine 5'-(tetrahydrogen triphosphate)
|
|
| Identifiers | |
|
3D model (Jmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.000.556 |
| MeSH | Cytidine+triphosphate |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C9H16N3O14P3 | |
| Molar mass | 483.156 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Cytidine triphosphate is a pyrimidine nucleoside triphosphate.
CTP, much like ATP, consists of a ribose sugar, and three phosphate groups. The major difference between the two molecules is the base used, which in CTP is cytosine.
CTP is a substrate in the synthesis of RNA.
CTP is a high-energy molecule similar to ATP, but its role as an energy coupler is limited to a much smaller subset of metabolic reactions. CTP is a coenzyme in metabolic reactions like the synthesis of glycerophospholipids and glycosylation of proteins.
CTP acts as an inhibitor of the enzyme Aspartate carbamoyltransferase, which is used in pyrimidine biosynthesis.